Griffin Asset Management’s Sanofi SNY Stock Holding History

Griffin Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-315	Closed	-$14K	–	441
2019 Q2	$14K	Buy	+315	New	+$13.4K	﹤0.01%	456
2015 Q4	–	Sell	-10,750	Closed	-$510K	–	98
2015 Q3	$510K	Buy	10,750 +2,000	+23%	+$102K	0.21%	71
2015 Q2	$433K	Buy	8,750 +500	+6%	+$25.3K	0.17%	74
2015 Q1	$408K	Buy	+8,250	New	+$394K	0.12%	85

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Griffin Asset Management's SNY Position: Q3 2019 in Review

Griffin Asset Management sold out of Sanofi (SNY) in Q3 2019, closing a stake of 315 shares — an estimated $14K sold.

Griffin Asset Management first reported a position in SNY in Q1 2015 and held it in 4 quarters. The position peaked at $510K in Q3 2015. 484 funds tracked by Wall St. Rank hold SNY as of Q3 2019.

Griffin Asset Management reported no remaining Sanofi position as of Q3 2019 after selling out during the quarter.
Griffin Asset Management sold 315 Sanofi shares in Q3 2019, an estimated $14K.
Griffin Asset Management first reported a position in Sanofi in Q1 2015 and held it in 4 quarters.
Griffin Asset Management's Sanofi position peaked at $510K in Q3 2015.
484 funds tracked by Wall St. Rank held Sanofi as of Q3 2019.

Based on Griffin Asset Management's 13F filing for Q3 2019, filed 5 Nov 2019.